Vaccine Information
Vaccination Plan for New Hampshire
Safe and Effective Vaccine
Safe and Effective Vaccine
The COVID-19 vaccine is safe, effective, and widely available to anyone 12 and older. It is our best defense against COVID-19. If you have questions/concerns about the vaccine, please review the information below or talk to your doctor. To find a vaccine near you, visit vaccines.gov.
COVID-19 Vaccination Provider Agreement
As additional COVID-19 vaccine becomes available for Phase 1b individuals and beyond, NH DHHS will distribute COVID-19 vaccines to provider offices, urgent care, pharmacies and other local health care facilities that have the capacity to offer vaccination to patients. To receive/administer COVID-19 vaccine, constituent products, and ancillary supplies, health care organizations that want to receive COVID-19 vaccine must enroll in the federal COVID-19 Vaccination Program coordinated through the New Hampshire Immunization Program. Enrolled COVID-19 vaccination providers must be credentialed/licensed in the jurisdiction where vaccination takes place and sign and agree to the conditions in the CDC COVID-19 Vaccination Program Provider Agreements. These conditions are detailed in the agreement itself. Note that NH DHHS will only be able to begin providing vaccine to these entities when vaccine supply allows.
In order to enroll as a COVID-19 vaccination provider, download the Provider Agreement complete the form electronically, being careful to follow the instructions, and email to C19Enrollment@dhhs.nh.gov.
- Provider Agreement Instructions
- Provider Agreement (must be downloaded and opened in Adobe Acrobat, not completed in the web browser)
Frequently Asked Questions
Resources for Families and Individuals
Educational Information and Resources
- COVID-19 Vaccine Training for Community Leaders: Presentation | Video Recording (May 4, 2021)
- Información sobre las vacunas contra el COVID-19: Presentación | Grabación de vídeo (Spanish)
Resources for Healthcare Providers
- Moderna COVID-19 Vaccine Storage & Handling
- Pfizer-BioNTech COVID-19 Vaccine Handling and Administration
- Janssen (J&J) COVID-19 Vaccine Storage, Dosage and Administration (April 27, 2021)
- CDC's COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians
- CDC COVID-19 Information for Healthcare Professionals and Jurisdictions
- CDC COVID-19 Vaccine Training Module: General Overview of Immunization Best Practices for Healthcare Professionals
Health Alert Network (HAN): COVID-19 vaccine related
- 05/12/2021: COVID-19 Update #43: Pfizer-BioNTech Vaccine Authorized for 12-15 Year Olds
- 04/24/2021: COVID-19 Update #42: Update on Johnson & Johnson (J&J) Janssen COVID-19 Vaccine
- 04/15/2021: COVID-19 Update #41: Update Regarding the Pause in Administration of the Johnson and Johnson Janssen COVID-19 Vaccine
- 04/13/2021: COVID-19 Update #40: Pause Administration of Johnson and Johnson Janssen COVID-19 Vaccine
- 04/08/2021: COVID-19 Update #39: Various Topics and Updated Partner Call Schedule
- 03/17/2021: COVID-19 Update #38: Updated Travel Guidance Quarantine Guidance for Schools
- 03/12/2021: COVID-19 Update #37: CDC Guidance for Fully Vaccinated Persons COVID-19 Vaccination Phase
- 03/04/2021: COVID-19 Update #36: Janssen COVID-19 Vaccine Receives FDA EUA; CDC Updates COVID-19 Vaccine; Clinical Recommendations Updated Vaccine Contraindications and Precautions
- 02/12/2021: COVID-19 Update #35: SARS-CoV-2 Variants of Concern
- 01/17/2021: COVID-19 Update #34b: Instructions for Registering Medically Vulnerable Patients for Vaccination
- 01/11/2021: COVID-19 Update #33: Vaccination Allocation Plan Update; Quarantine Guidance Update
- 12/31/2020: COVID-19 Update #32: CDC Updates COVID-19 Vaccine Clinical Guidance Changes to Vaccine Contraindications and Precautions
- 12/29/2020:COVID-19 Update #31: Instructions for Ambulatory Care Providers to Access Vaccine Instructions for Enrolling to Become a Vaccine Provider
- 12/20/2020: COVID-19 Update #30: Moderna COVID-19 Vaccine Receives EUA, CDC and ACIP Issue Recommendations for Use; Update on Doses of Pfizer-BioNTech Vaccine in Multi-Dose Vials
- 12/13/2020: COVID-19 Update #29: Pfizer-BioNTech COVID-19 Vaccine Receives EUA, CDC and ACIP Issue Recommendations for Use
- 12/11/2020: COVID-19 Update #28: Vaccine Allocation and Administration Guidelines for Phase 1a New Vaccine Frequently Asked Questions (FAQs)
Media and Press
NH DHHS Immunization Program
Archive
- View the Archive of Vaccination Information